Abeona Therapeutics (ABEO) EBT Margin (2011 - 2026)

Abeona Therapeutics' EBT Margin history runs 13 years deep, the most recent figure standing at 195.79% for Q1 2026.

• In Q1 2026, EBT Margin changed N/A year-over-year to 195.79%; the TTM figure through Mar 2026 stood at 455.56% (changed N/A YoY), while the FY2025 annual figure was 1224.79%, changed N/A from the prior year.
• EBT Margin for Q1 2026 stood at 195.79%, up from 381.46% in the prior quarter.
• The five-year high for EBT Margin was 31086.25% in Q2 2025, with the low at 19285.29% in Q4 2022.
• The 4-year median for EBT Margin is 381.46% (2025), against an average of 34.76%.
• Peak annual rise in EBT Margin reached 154216 bps in 2023, while the deepest fall reached 154216 bps in 2023.
• Abeona Therapeutics' EBT Margin stood at 19285.29% in 2022, then soared by 98 bps to 324.14% in 2023, then retreated by 18 bps to 381.46% in 2025, then surged by 49 bps to 195.79% in 2026.
• Business Quant data shows ABEO's EBT Margin at 195.79% in Q1 2026, 381.46% in Q4 2025, and 31086.25% in Q2 2025.